Keys to successful management of patients with allergic rhinitis: Focus on patient confidence, compliance, and satisfaction

Asthma and Allergy Foundation of America (AAFA) Consumer Survey 2005www.aafa.org/display.cfm?id=7&sub=92&cont=529. 10.1067/mai.2001.115569 10.1016/S1081-1206(10)62026-1 10.5694/j.1326-5377.2005.tb06551.x American College of Allergy Asthma & ImmunologyAdvice From Your Allergist: Rhinitis.http://www.acaai.org/public/advice/rhin.htm. 10.1016/S1081-1206(10)63155-9 Gallup Study of Allergies 2005 (Phase II Report)http://multispon‐sorsurveys.com. 10.1111/j.1399-3038.1997.tb00156.x 10.1034/j.1398-9995.2000.00672.x 10.1016/S0091-6749(97)70126-X 10.1111/j.1398-9995.1989.tb02234.x 10.3109/00016489409124319 Allergy ReportThe American Academy of Allergy Asthma & Immunology 2000.http://www.theallergyreport.com/reportindex.html. 10.1067/mai.2002.121701 10.1016/S0091-6749(95)70090-0 10.1016/S0091-6749(97)70274-4 10.1034/j.1398-9995.57.s75.2.x 10.1016/j.otohns.2004.02.001 10.1016/S0091-6749(97)80041-3 10.1053/ai.1994.v94.a54939 Vuurman EF, 1993, Seasonal allergic rhinitis and antihistamine effects on children's learning, Ann Allergy, 71, 121 10.1016/S1081-1206(10)62273-9 10.1016/S1081-1206(10)62022-4 10.1016/S1081-1206(10)63367-4 Tanner LA, 1999, Effect of fexofenadine HCI on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis., Am J Managed Care, 5, S235 10.1016/S1081-1206(10)62671-3 10.1185/030079906X112552 10.1016/S0091-6749(99)70463-X 2003, Fast Stats A‐Z. Vital and Health Statistics 1997, Am J Manag Care, 3, S8 Crystal‐Peters J, 2000, The cost of productivity losses associated with allergic rhinitis, Am J Manag Care, 6, 373 10.1067/mai.2001.118891 10.1016/j.amjmed.2005.06.015 Gelfand EW, 2003, Current trends in allergic rhinitis: a multidisciplinary approach to patient management, Clinician, 21, 1 10.1111/j.1398-9995.1996.tb04772.x 2006, Physicians' Desk Reference 10.1056/NEJMra033121 10.2165/00044011-200121010-00004 10.1016/S1081-1206(10)62086-8 10.1067/mai.2003.168 10.1016/S0091-6749(96)70155-0 10.1111/j.1398-9995.1993.tb00741.x 10.1067/mai.2000.106040 10.1016/S1081-1206(10)62855-4 Meltzer EO, 1996, Productivity costs of antihistamines in the workplace, Occup Health Saf, 65, 46 10.1038/clpt.1989.3 10.1001/archinte.1997.00440410082009 10.1002/(SICI)1097-0274(199608)30:2<234::AID-AJIM16>3.0.CO;2-Y 10.1067/mai.2000.106153 2006, Physicians' Desk Reference for Nonprescription Drugs Yap YG, 2002, Potential cardiac toxicity of H1‐antihistamines, Clin Allergy Immunol, 17, 389 10.1016/j.clinthera.2005.04.012 Astelin® (azelastine) prescribing informationMedPointe Pharmaceuticals August 2000. Lefkowitz RJ, 1996, The Pharmacological Basis of Therapeutics, 105 Grosclaude M, 1997, Cetirizine and pseudoephedrine retard, given alone or in combination, in patients with seasonal allergic rhinitis, Rhinology, 35, 67 10.1177/014556130007900410 Schenkel E, 2002, Efficacy of once‐daily desloratadine/pseudoephedrine for relief of nasal congestion, Allergy Asthma Proc, 23, 325 2005, Phenylpropanolamine‐containing drug products for over‐the‐counter human use; tentative final monographs., Federal Register, 70, 75988 10.1056/NEJM200012213432501 10.1001/archinte.1992.00400180098015 Black MJ, 1980, Rhinitis medicamentosa, Can Med Assoc J, 122, 881 10.1034/j.1398-9995.2002.23625.x 10.1592/phco.22.16.1458.33692 10.1056/NEJM199503303321307 10.1034/j.1398-9995.2002.03228.x 10.1016/S1081-1206(10)63030-X 10.2500/105065897781446658 10.1016/S0091-6749(98)70326-4 10.1136/bmj.317.7173.1624 10.1001/archotol.129.5.557 10.2500/108854199778553037 10.1016/S1081-1206(10)63161-4 Ratner PH, 1998, A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis, J Fam Pract, 47, 118 10.1007/s11882-002-0092-0 10.1016/S1081-1206(10)61911-4 10.1016/S1081-1206(10)62025-X 10.1046/j.1365-2222.2002.01422.x 10.1016/S1081-1206(10)61891-1 10.1016/S1081-1206(10)61018-6 10.1016/S1081-1206(10)62138-2 10.1016/0091-6749(85)90725-0 10.1152/jappl.1993.74.6.2661 10.1164/ajrccm.149.6.7516250 10.2500/108854198778557962 10.1016/0091-6749(92)90078-G 10.1016/S0091-6749(95)70215-6 10.1016/S0091-6749(95)70216-4 10.1016/S1081-1206(10)63284-X 10.1177/014556139707600809 10.1067/mai.2001.112027 10.1111/j.1398-9995.2005.00790.x Ferrer M, 2005, Double‐blind, placebo‐controlled study of immunotherapy with Parietaria judaica: clinical efficacy and tolerance, J Invest Allergol Clin Immunol, 15, 283 10.1016/j.jaci.2005.06.004 10.1016/j.jaci.2005.11.014 10.1111/j.1398-9995.2006.01011.x 10.1056/NEJM199908123410702 Valovirta E, 1997, Capacity of specific immunotherapy in prevention of allergic asthma in children: the Preventive Allergy Treatment Study (PAT), J Investig Allergol Clin Immunol, 7, 369 10.1067/mai.2002.121317 10.1111/j.1398-9995.2004.00537.x 10.1186/1465-9921-6-153 10.1016/S0091-6749(97)70069-1 10.1046/j.1365-2222.2001.01161.x 10.1046/j.1365-2222.2001.01027.x 10.2500/108854100778149007 10.1067/mai.2003.129 10.1016/j.jaci.2006.02.040 10.1111/j.1398-9995.1998.tb04086.x 10.1056/NEJM199912233412603 10.1067/mai.2000.108310 10.1001/jama.286.23.2956 10.1067/mai.2002.121949 10.1016/j.jaci.2004.12.218 PatelPWallGMBenningerPJDose response duration and onset of action of olopatadine nasal spray. Poster no. 258 presented at the American College of Allergy Asthma & Immunology Annual Meeting. November 12‐17 2004; Boston MA. 10.1016/S1081-1206(10)61174-X 10.1016/S1081-1206(10)61025-3 10.1358/dot.2004.40.7.850475 10.1016/j.jaci.2003.12.055 10.2500/108854100778248953 McLoughlin J, 1983, The relationship of allergies and allergy treatment to school performance and student behavior, Ann Allergy, 51, 506 10.1016/S1081-1206(10)61640-7 10.1002/ajim.10285 10.7326/0003-4819-132-5-200003070-00004 10.1164/ajrccm.149.2.8306032 Blaiss MS, 2003, Important aspects in management of allergic rhinitis: compliance, cost, and quality of life, Allergy Asthma Proc, 24, 231 10.1016/S0277-9536(02)00056-4 10.1001/jama.291.19.2359 10.1001/jama.1984.03350170043017 10.1046/j.1525-1497.1997.00057.x 10.1001/jama.282.24.2313